 |
|
Rarity of Diabetic Retinopathy in Patients With Acromegaly
Elmer J. Ballintine, MD;
Scott Foxman, MD;
Phillip Gorden, MD;
Jesse Roth, MD
Arch Intern Med. 1981;141(12):1625-1627.
Abstract
• We studied 44 acromegalic patients with the use of fluorescein angiography to detect the presence of diabetic retinopathy. We found elements of diabetic retinopathy in only one patient (2.2%). The average patient had a growth hormone concentration of 32 ng/mL (range, 1 to 275 ng/mL) for a duration of 10.5 years (range, three to 26 years). Forty-five percent (20) of our group had glucose intolerance and 14% (six) had elevated fasting blood glucose levels for an average duration of two years (range, one to four years). We conclude that diabetic retinopathy is an uncommon finding in patients with acromegaly and that fluorescein angiography does not reveal cases that were not detected by conventional funduscopic examination.
(Arch Intern Med 1981;141:1625-1627)
Author Affiliations
From the National Eye Institute (Drs Ballintine and Foxman) and the National Institute of Arthritis, Metabolism, and Digestive Diseases (Drs Gorden and Roth), National Institutes of Health, Bethesda, Md.
Footnotes
Accepted for publication Nov 3, 1980.
Reprint requests to Bldg 10, Room 9N222, National Institutes of Health, Bethesda, MD 20205 (Dr Gorden).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Peptide Hormone Regulation of Angiogenesis
Clapp et al.
Physiol. Rev. 2009;89:1177-1215.
ABSTRACT
| FULL TEXT
Increased Intraocular Insulin-like Growth Factor-I Triggers Blood-Retinal Barrier Breakdown
Haurigot et al.
J. Biol. Chem. 2009;284:22961-22969.
ABSTRACT
| FULL TEXT
Severe proliferative diabetic retinopathy associated with acromegaly
INOKUCHI et al.
Br J Ophthalmol 1999;83:628c-628.
FULL TEXT
|
